Reversing deleterious protein aggregation with re-engineered protein disaggregases

References

• Dobson CM. Protein folding and misfolding. Nature 2003; 426:884 - 90; http://dx.doi.org/10.1038/nature02261; PMID: 14685248
   PubMed Web of Science ®Google Scholar
• Forman MS, Trojanowski JQ, Lee VM. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat Med 2004; 10:1055 - 63; http://dx.doi.org/10.1038/nm1113; PMID: 15459709
   PubMed Web of Science ®Google Scholar
• Morimoto RI. Stress, aging, and neurodegenerative disease. N Engl J Med 2006; 355:2254 - 5; http://dx.doi.org/10.1056/NEJMcibr065573; PMID: 17124027
   PubMed Web of Science ®Google Scholar
• Robberecht W, Philips T. The changing scene of amyotrophic lateral sclerosis. Nat Rev Neurosci 2013; 14:248 - 64; http://dx.doi.org/10.1038/nrn3430; PMID: 23463272
   PubMed Web of Science ®Google Scholar
• King OD, Gitler AD, Shorter J. The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease. Brain Res 2012; 1462:61 - 80; http://dx.doi.org/10.1016/j.brainres.2012.01.016; PMID: 22445064
   PubMed Web of Science ®Google Scholar
• Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006; 314:130 - 3; http://dx.doi.org/10.1126/science.1134108; PMID: 17023659
   PubMed Web of Science ®Google Scholar
• Vance C, Rogelj B, Hortobágyi T, De Vos KJ, Nishimura AL, Sreedharan J, Hu X, Smith B, Ruddy D, Wright P, et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 2009; 323:1208 - 11; http://dx.doi.org/10.1126/science.1165942; PMID: 19251628
   PubMed Web of Science ®Google Scholar
• Kwiatkowski TJ Jr., Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, Russ C, Davis A, Gilchrist J, Kasarskis EJ, Munsat T, et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 2009; 323:1205 - 8; http://dx.doi.org/10.1126/science.1166066; PMID: 19251627
   PubMed Web of Science ®Google Scholar
• Cushman M, Johnson BS, King OD, Gitler AD, Shorter J. Prion-like disorders: blurring the divide between transmissibility and infectivity. J Cell Sci 2010; 123:1191 - 201; http://dx.doi.org/10.1242/jcs.051672; PMID: 20356930
   PubMed Web of Science ®Google Scholar
• Luk KC, Kehm V, Carroll J, Zhang B, O’Brien P, Trojanowski JQ, Lee VM. Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 2012; 338:949 - 53; http://dx.doi.org/10.1126/science.1227157; PMID: 23161999
   PubMed Web of Science ®Google Scholar
• Guo JL, Covell DJ, Daniels JP, Iba M, Stieber A, Zhang B, Riddle DM, Kwong LK, Xu Y, Trojanowski JQ, et al. Distinct α-synuclein strains differentially promote tau inclusions in neurons. Cell 2013; 154:103 - 17; http://dx.doi.org/10.1016/j.cell.2013.05.057; PMID: 23827677
   PubMed Web of Science ®Google Scholar
• Kim YE, Hipp MS, Bracher A, Hayer-Hartl M, Hartl FU. Molecular chaperone functions in protein folding and proteostasis. Annu Rev Biochem 2013; 82:323 - 55; http://dx.doi.org/10.1146/annurev-biochem-060208-092442; PMID: 23746257
   PubMed Web of Science ®Google Scholar
• Warrick JM, Paulson HL, Gray-Board GL, Bui QT, Fischbeck KH, Pittman RN, Bonini NM. Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila.. Cell 1998; 93:939 - 49; http://dx.doi.org/10.1016/S0092-8674(00)81200-3; PMID: 9635424
   PubMed Web of Science ®Google Scholar
• Cushman-Nick M, Bonini NM, Shorter J. Hsp104 suppresses polyglutamine-induced degeneration post onset in a drosophila MJD/SCA3 model. PLoS Genet 2013; 9:e1003781; http://dx.doi.org/10.1371/journal.pgen.1003781; PMID: 24039611
   PubMed Web of Science ®Google Scholar
• Torrente MP, Shorter J. The metazoan protein disaggregase and amyloid depolymerase system: Hsp110, Hsp70, Hsp40, and small heat shock proteins. Prion 2014; 7; PMID: 24401655
   PubMed Web of Science ®Google Scholar
• Duennwald ML, Echeverria A, Shorter J. Small heat shock proteins potentiate amyloid dissolution by protein disaggregases from yeast and humans. PLoS Biol 2012; 10:e1001346; http://dx.doi.org/10.1371/journal.pbio.1001346; PMID: 22723742
   PubMed Web of Science ®Google Scholar
• Shorter J. The mammalian disaggregase machinery: Hsp110 synergizes with Hsp70 and Hsp40 to catalyze protein disaggregation and reactivation in a cell-free system. PLoS One 2011; 6:e26319; http://dx.doi.org/10.1371/journal.pone.0026319; PMID: 22022600
   PubMed Web of Science ®Google Scholar
• Rampelt H, Kirstein-Miles J, Nillegoda NB, Chi K, Scholz SR, Morimoto RI, Bukau B. Metazoan Hsp70 machines use Hsp110 to power protein disaggregation. EMBO J 2012; 31:4221 - 35; http://dx.doi.org/10.1038/emboj.2012.264; PMID: 22990239
   PubMed Web of Science ®Google Scholar
• Mattoo RU, Sharma SK, Priya S, Finka A, Goloubinoff P. Hsp110 is a bona fide chaperone using ATP to unfold stable misfolded polypeptides and reciprocally collaborate with Hsp70 to solubilize protein aggregates. J Biol Chem 2013; 288:21399 - 411; http://dx.doi.org/10.1074/jbc.M113.479253; PMID: 23737532
   PubMed Web of Science ®Google Scholar
• Shorter J. Hsp104: a weapon to combat diverse neurodegenerative disorders. Neurosignals 2008; 16:63 - 74; http://dx.doi.org/10.1159/000109760; PMID: 18097161
   PubMed Web of Science ®Google Scholar
• Glover JR, Lindquist S. Hsp104, Hsp70, and Hsp40: a novel chaperone system that rescues previously aggregated proteins. Cell 1998; 94:73 - 82; http://dx.doi.org/10.1016/S0092-8674(00)81223-4; PMID: 9674429
   PubMed Web of Science ®Google Scholar
• Vashist S, Cushman M, Shorter J. Applying Hsp104 to protein-misfolding disorders. Biochem Cell Biol 2010; 88:1 - 13; http://dx.doi.org/10.1139/O09-121; PMID: 20130674
   PubMed Web of Science ®Google Scholar
• DeSantis ME, Leung EH, Sweeny EA, Jackrel ME, Cushman-Nick M, Neuhaus-Follini A, Vashist S, Sochor MA, Knight MN, Shorter J. Operational plasticity enables hsp104 to disaggregate diverse amyloid and nonamyloid clients. Cell 2012; 151:778 - 93; http://dx.doi.org/10.1016/j.cell.2012.09.038; PMID: 23141537
   PubMed Web of Science ®Google Scholar
• Lo Bianco C, Shorter J, Régulier E, Lashuel H, Iwatsubo T, Lindquist S, Aebischer P. Hsp104 antagonizes alpha-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease. J Clin Invest 2008; 118:3087 - 97; http://dx.doi.org/10.1172/JCI35781; PMID: 18704197
   PubMed Web of Science ®Google Scholar
• Sweeny EA, Shorter J. Prion proteostasis: Hsp104 meets its supporting cast. Prion 2008; 2:135 - 40; http://dx.doi.org/10.4161/pri.2.4.7952; PMID: 19242125
   PubMed Web of Science ®Google Scholar
• Jackrel ME, DeSantis ME, Martinez BA, Castellano LM, Stewart RM, Caldwell KA, Caldwell GA, Shorter J. Potentiated Hsp104 variants antagonize diverse proteotoxic misfolding events. Cell 2014; 156:170 - 82; http://dx.doi.org/10.1016/j.cell.2013.11.047; PMID: 24439375
   PubMed Web of Science ®Google Scholar
• Vacher C, Garcia-Oroz L, Rubinsztein DC. Overexpression of yeast hsp104 reduces polyglutamine aggregation and prolongs survival of a transgenic mouse model of Huntington’s disease. Hum Mol Genet 2005; 14:3425 - 33; http://dx.doi.org/10.1093/hmg/ddi372; PMID: 16204350
   PubMed Web of Science ®Google Scholar
• Warrick JM, Chan HYE, Gray-Board GL, Chai Y, Paulson HL, Bonini NM. Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70. Nat Genet 1999; 23:425 - 8; http://dx.doi.org/10.1038/70532; PMID: 10581028
   PubMed Web of Science ®Google Scholar
• Kuo Y, Ren S, Lao U, Edgar BA, Wang T. Suppression of polyglutamine protein toxicity by co-expression of a heat-shock protein 40 and a heat-shock protein 110. Cell Death Dis 2013; 4:e833; http://dx.doi.org/10.1038/cddis.2013.351; PMID: 24091676
   PubMed Web of Science ®Google Scholar
• DeSantis ME, Shorter J. The elusive middle domain of Hsp104 and ClpB: location and function. Biochim Biophys Acta 2012; 1823:29 - 39; http://dx.doi.org/10.1016/j.bbamcr.2011.07.014; PMID: 21843558
   PubMed Web of Science ®Google Scholar
• Tessarz P, Mogk A, Bukau B. Substrate threading through the central pore of the Hsp104 chaperone as a common mechanism for protein disaggregation and prion propagation. Mol Microbiol 2008; 68:87 - 97; http://dx.doi.org/10.1111/j.1365-2958.2008.06135.x; PMID: 18312264
   PubMed Web of Science ®Google Scholar
• Saibil H. Chaperone machines for protein folding, unfolding and disaggregation. Nat Rev Mol Cell Biol 2013; 14:630 - 42; http://dx.doi.org/10.1038/nrm3658; PMID: 24026055
   PubMed Web of Science ®Google Scholar
• Gitler AD. Beer and bread to brains and beyond: can yeast cells teach us about neurodegenerative disease?. Neurosignals 2008; 16:52 - 62; http://dx.doi.org/10.1159/000109759; PMID: 18097160
   PubMed Web of Science ®Google Scholar
• Khurana V, Lindquist S. Modelling neurodegeneration in Saccharomyces cerevisiae: why cook with baker’s yeast?. Nat Rev Neurosci 2010; 11:436 - 49; http://dx.doi.org/10.1038/nrn2809; PMID: 20424620
   PubMed Web of Science ®Google Scholar
• Johnson BS, McCaffery JM, Lindquist S, Gitler AD. A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicity. Proc Natl Acad Sci U S A 2008; 105:6439 - 44; http://dx.doi.org/10.1073/pnas.0802082105; PMID: 18434538
   PubMed Web of Science ®Google Scholar
• Sun Z, Diaz Z, Fang X, Hart MP, Chesi A, Shorter J, Gitler AD. Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS. PLoS Biol 2011; 9:e1000614; http://dx.doi.org/10.1371/journal.pbio.1000614; PMID: 21541367
   PubMed Web of Science ®Google Scholar
• Ju S, Tardiff DF, Han H, Divya K, Zhong Q, Maquat LE, Bosco DA, Hayward LJ, Brown RH Jr., Lindquist S, et al. A yeast model of FUS/TLS-dependent cytotoxicity. PLoS Biol 2011; 9:e1001052; http://dx.doi.org/10.1371/journal.pbio.1001052; PMID: 21541368
   PubMed Web of Science ®Google Scholar
• Outeiro TF, Lindquist S. Yeast cells provide insight into alpha-synuclein biology and pathobiology. Science 2003; 302:1772 - 5; http://dx.doi.org/10.1126/science.1090439; PMID: 14657500
   PubMed Web of Science ®Google Scholar
• Elden AC, Kim H-J, Hart MP, Chen-Plotkin AS, Johnson BS, Fang X, Armakola M, Geser F, Greene R, Lu MM, et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 2010; 466:1069 - 75; http://dx.doi.org/10.1038/nature09320; PMID: 20740007
   PubMed Web of Science ®Google Scholar
• Tardiff DF, Jui NT, Khurana V, Tambe MA, Thompson ML, Chung CY, Kamadurai HB, Kim HT, Lancaster AK, Caldwell KA, et al. Yeast reveal a “druggable” Rsp5/Nedd4 network that ameliorates α-synuclein toxicity in neurons. Science 2013; 342:979 - 83; http://dx.doi.org/10.1126/science.1245321; PMID: 24158909
   PubMed Web of Science ®Google Scholar
• Chung CY, Khurana V, Auluck PK, Tardiff DF, Mazzulli JR, Soldner F, Baru V, Lou Y, Freyzon Y, Cho S, et al. Identification and rescue of α-synuclein toxicity in Parkinson patient-derived neurons. Science 2013; 342:983 - 7; http://dx.doi.org/10.1126/science.1245296; PMID: 24158904
   PubMed Web of Science ®Google Scholar
• Berkowitz LA, Hamamichi S, Knight AL, Harrington AJ, Caldwell GA, Caldwell KA. Application of a C. elegans dopamine neuron degeneration assay for the validation of potential Parkinson’s disease genes. J Vis Exp 2008; e835; PMID: 19066512
   PubMedGoogle Scholar
• Cooper AA, Gitler AD, Cashikar A, Haynes CM, Hill KJ, Bhullar B, Liu K, Xu K, Strathearn KE, Liu F, et al. α-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson’s models. Science 2006; 313:324 - 8; http://dx.doi.org/10.1126/science.1129462; PMID: 16794039
   PubMed Web of Science ®Google Scholar